Expert recommendations for the management of fecal incontinence in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) Gastrointestinal “Ad hoc committee”

By afschroeder • June 19, 2026

McMahan ZH, Santis MC, Cricchio AL, Alcala-Gonzalez LG, Clarke J, O'Connor A, Bellando-Randone S, Denton CP, Galetti I, Lescoat A, Matucci-Cerinic M, Matucci-Cerinic P, McLaughlin J, Murray C, Volkmann ER, Alunno A, Bandini G, Hughes M. Expert recommendations for the management of fecal incontinence in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) Gastrointestinal "Ad hoc committee". J Scleroderma Relat Disord. 2026 Jan;11(1):e000022. doi: 10.1136/jsrd-2026-000022. Epub 2026 Jan 1. PMID: 42317568; PMCID: PMC13274632.

Tags: Fecal incontinence, gastrointestinal involvement, guidelines, Publications, Rheumatology, systemic sclerosis, World Scleroderma Foundation

Pregnancy in Autosomal Dominant Polycystic Kidney Disease: Maternal and Fetal Considerations: A Narrative Review

Sarmadian PJ, Pirooz AD, Al Baghdadi M, Kamgar M, Afshar Y, Nobakht N. Pregnancy in Autosomal Dominant Polycystic Kidney Disease: Maternal and Fetal Considerations: A[...]

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial

Mease PJ, Chandran V, Armstrong AW, Blanco R, Ogdie A, Siegel EL, Gottlieb AB, Zeng X, Thaçi D, Kishimoto M, Schulze-Koops H, Kivitz A, Dokoupilová[...]

Impact of clonal hematopoiesis of indeterminate potential on treatment outcomes in multiple myeloma patients undergoing CAR-T cell therapy

Carlson SG, Puliafito BR, Kawai K, Senaratne TN, Lee TD, Lin T, Timmerman J, Larson SM. Impact of clonal hematopoiesis of indeterminate potential on treatment[...]